Lancet Respiratory Medicine,The
Công bố khoa học tiêu biểu
* Dữ liệu chỉ mang tính chất tham khảo
Sắp xếp:
Efficacy and safety of pembrolizumab in patients with advanced mesothelioma in the open-label, single-arm, phase 2 KEYNOTE-158 study
Lancet Respiratory Medicine,The - Tập 9 Số 6 - Trang 613-621 - 2021
Ipilimumab and nivolumab in the treatment of recurrent malignant pleural mesothelioma (INITIATE): results of a prospective, single-arm, phase 2 trial
Lancet Respiratory Medicine,The - Tập 7 Số 3 - Trang 260-270 - 2019
Optimising clinical trials in acute myocardial infarction complicated by cardiogenic shock: a statement from the 2020 Critical Care Clinical Trialists Workshop
Lancet Respiratory Medicine,The - Tập 9 - Trang 1192-1202 - 2021
Protecting health-care workers from subclinical coronavirus infection
Lancet Respiratory Medicine,The - Tập 8 Số 3 - Trang e13 - 2020
Endobronchial coils for the treatment of severe emphysema with hyperinflation (RESET): a randomised controlled trial
Lancet Respiratory Medicine,The - Tập 1 Số 3 - Trang 233-240 - 2013
Lung volume reduction for emphysema
Lancet Respiratory Medicine,The - Tập 5 Số 2 - Trang 147-156 - 2017
Hyperinflation in COPD exacerbations
Lancet Respiratory Medicine,The - Tập 3 Số 12 - Trang e43-e44 - 2015
Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial
Lancet Respiratory Medicine,The - Tập 7 - Trang 154-162 - 2019
Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
Lancet Respiratory Medicine,The - Tập 10 - Trang 1137-1146 - 2022
Diagnostic accuracy of transbronchial lung cryobiopsy for interstitial lung disease diagnosis (COLDICE): a prospective, comparative study
Lancet Respiratory Medicine,The - Tập 8 Số 2 - Trang 171-181 - 2020
Tổng số: 432
- 1
- 2
- 3
- 4
- 5
- 6
- 44